Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Overall Survival for Metastatic Colorectal Cancer Patients Matched to CHECKMATE-142

NCT05420909 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT05420909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05420909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Overall Survival for Metastatic Colorectal Cancer Patients Matched to CHECKMATE-142
Lead sponsor
Bristol-Myers Squibb
Phase
Observational
Overall status
Completed
Start date
January 28, 2019
Completion date
April 1, 2019
Enrollment
124 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer (mcrc)